Recombinant Human alpha 1 Antitrypsin rh-AAT

Recombinant Human alpha 1 Antitrypsin
General description
Alpha 1 proteinase inhibitor (Antitrypsin) has a characteristic secondary structure of beta sheets and alpha helices. That is a serum glycoprotein synthesized in the liver. It acts as an elastase inhibitor, primarily inhibiting neutrophil elastase, chymotrypsin, collagenase, leucocytic proteases, plasmin, and thrombin, which may be released during inflammatory reactions in the lung. Also Increase in Antitrypsin occurs as an acute phase response to tissue necrosis and inflammation. Serum level of Antitrypsin is elevated in rheumatoid arthritis, bacterial infections, vasculitis, and carcinomatosis. Recombinant Antitrypsin protein was expressed in E.coli and purified by using conventional chromatography techniques.
CAS NO.: 
Source: E. coli (No animal components are used in the manufacturing process of this product, animal-free material.)
Form: Lyophilized
Mol. Weight: 43.2kDa
Appearance: White Power
Purity:  ≥95% (SDS-PAGE)
Endotoxin:  < 1.EU/mg (kinetic LAL)
Reconstitution: Dissolve with distilled water
Package: 500ug, 1mg, 5mg, 10mg, 1g
Storage&Shift life: -20ºC 2years 
Application: Cell Culture and research
Limitations: For LABORATORY RESEARCH USE ONLY and is not approved for use in humans or clinical.